Lund Melanoma Study Group
131 – 140 of 225
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
(
- Contribution to journal › Article
-
Mark
The genetic evolution of melanoma
2018) p.105-114(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
(
- Contribution to journal › Article
-
Mark
High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort
(
- Contribution to journal › Article
-
Mark
Association analysis identifies 65 new breast cancer risk loci
(
- Contribution to journal › Article
-
Mark
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Cancer risks and survival in patients with multiple primary melanomas : Association with family history of melanoma and germline CDKN2A mutation status
(
- Contribution to journal › Article
-
Mark
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families
(
- Contribution to journal › Article
-
Mark
Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Predominance of girls with cancer in families with multiple childhood cancer cases
(
- Contribution to journal › Article